Your search for evid returned 2822 results

Treatment with Prolia was associated with greater reductions in the overall relative risk across various fracture types.

Researchers looked at the use of 6 biosimilars across 38 oncology practices and found that biosimilar use increased from 2019 to 2021.

Donanemab is an investigational antibody therapy that targets a modified form of deposited amyloid-β peptide called N3pG.

Moderate net benefit found for preventing active tuberculosis disease by screening persons at increased risk for infection.

Bemnifosbuvir is currently being evaluated in the phase 3 SUNRISE-3 trial, which includes high-risk outpatients with COVID-19.

Friday’s order is the second time in a year that the Supreme Court has considered slashing access to abortion in the United States.

There are currently no FDA-approved therapies targeting exon 44.

Overall, 17.7 cases of myocarditis reported per million vaccinations; 77 percent had symptom resolution at time of report.

New instrument, the Pain-related OUD Exacerbation Scale, shows validity

Findings based on comparisons for chlamydia, gonorrhea, and trichomoniasis.